跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EPIPEN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
EPIPEN
Authorized
STANDARD
EPIPEN
Mylan Specialty LP
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2dc21e6682f0305f
Company
Mylan Specialty LP
Type
Standard
Approval Details
Approval Id
2dc21e6682f0305f
Drug Approval Canada Name
EPIPEN
Product Name
EPIPEN
Status
Marketed
Status Date
2013-03-22
Original Market Date
1980-12-31
Din
00509558
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular
Schedule
Ethical
Ahfs
12:12.12
Atc Original
C01CA24 EPINEPHRINE
Atc Name
c 01 ca 24
Aig Number
0104871002
Company Name
Mylan Specialty LP
Company Address
3711 Collins Ferry Road, Morgantown, West Virginia, United States, 26505
Company Detail Path
/organization/mylan-specialty-lp
Company Information
Pharmaceutical Company Name
Mylan Specialty LP
Country Name
United States
Province Name
California
City Name
加利福尼亚州纳帕县
Website
http://www.mylanspecialty.com
Active Ingredients
EPINEPHRINE
0.3 MG / 0.3 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2dc21e6682f0305f
Type
Standard
Back to Health Canada Approvals